Action ABIO ARCA BIOPHARMA, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues ARCA biopharma, Inc.

Actions

ABIO

US00211Y5069

Marché Fermé - Nasdaq
Autres places de cotation
 22:30:00 03/05/2024 		Varia. 5j. Varia. 1 janv.
3,26 USD 0,00% Graphique intraday de ARCA biopharma, Inc. -8,94% +91,76%
25/04 ARCA biopharma, Inc. déclare ses résultats pour le premier trimestre clos le 31 mars 2024 CI
04/04 ARCA biopharma, Inc. annonce des changements au sein de sa direction CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
ARCA biopharma Announces First Quarter 2024 Financial Results and Provides Corporate Update
ARCA biopharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
North American Morning Briefing : Stock Futures -2-
SHAREHOLDER INVESTIGATION: The M&A Class Action Firm Announces an Investigation of ARCA Biopharma, Inc. - ABIO
ARCA BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of ARCA biopharma, Inc. - ABIO
ARCA biopharma, Inc. Announces Management Changes
ARCA biopharma, Inc. Announces Separation of Michael Bristow, Chief Executive Officer
Sector Update: Health Care Stocks Softer Late Afternoon
Shareholder Alert: Ademi LLP investigates whether ARCA biopharma, Inc. has obtained a Fair Price in its transaction with Oruka
Top Midday Gainers
Sector Update: Health Care Stocks Rise Wednesday Afternoon
Sector Update: Health Care
ARCA biopharma, Oruka Therapeutics Announce All-Stock Merger; Shares Surge
ABIO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of ARCA Biopharma, Inc. Is Fair to Shareholders
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
Oruka Therapeutics announced that it expects to receive $275 million in funding
ARCA biopharma Announces 2023 Financial Results
ARCA biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
ARCA biopharma Announces Third Quarter 2023 Financial Results
ARCA biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action ABIO
  4. Actualités ARCA biopharma, Inc.
  5. Autres langues